This inventor holds 9 USPTO granted patents. Top assignees: Bayer Corporation, Aerovance, Inc., Bayer Pharmaceuticals Corporation. Active years: 1994-2008.
Company Filing History:
6 out of 1,013 
1 out of 6 
1 out of 71 
Years Active: 1994-2008
Title: Gary Davis: Innovator in Biopharmaceuticals
Introduction
Gary Davis is a notable inventor based in Milford, CT (US), recognized for his contributions to the field of biopharmaceuticals. With a total of 9 patents to his name, Davis has made significant strides in developing innovative methods and compositions that address critical health challenges.
Latest Patents
Among his latest patents, Davis has developed a method for utilizing human placental bikunin, which includes proteins, polypeptides, nucleic acid sequences, constructs, expression vectors, host cells, and pharmaceutical compositions. This invention provides a comprehensive approach to harnessing the therapeutic potential of human bikunin. Additionally, he has created antiviral methods using the human rhinovirus receptor (ICAM-1). This method involves inhibiting human rhinovirus (HRV) infection by contacting HRV with a polypeptide that comprises a fragment of the human rhinovirus major receptor, specifically targeting the HRV binding site.
Career Highlights
Throughout his career, Gary Davis has worked with prominent organizations, including Bayer Corporation and the Government of the United States of America. His work has significantly impacted the development of antiviral therapies and biopharmaceutical innovations.
Collaborations
Davis has collaborated with esteemed colleagues such as Jeffrey M. Greve and Alan McClelland, contributing to a rich exchange of ideas and advancements in their respective fields.
Conclusion
Gary Davis stands out as a pioneering inventor in the biopharmaceutical sector, with a focus on innovative solutions for health-related challenges. His contributions continue to influence the landscape of medical research and development.